Maria Silvina Lo Presti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria Silvina Lo Presti has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Mariana Strauss
Centro de Estudios e Investigación de la Enfermedad de Chagas y Leishmaniasis, FCM, INICSA-CONICET-UNC, Córdoba, Argentina
14 shared publications Patricia A. Paglini-Oliva
Universidad Nacional de Córdoba, Facultad de Ciencias Médicas, Instituto de Investigaciones en Ciencias de la Salud, Centro de Estudios e Investigación de la Enfermedad de Chagas y Leishmaniasis, INICSA-CONICET, Córdoba, Argentina
8 shared publicationsRicardo Fretes
Cátedra de Biología Celular Embriología y Genética, FCM, UNC, Córdoba, Argentina
8 shared publicationsAlejandra L. Báez
Centro de Investigación de la Enfermedad de Chagas y Leishmaniasis (CIECyL), Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Argentina; Instituto de Investigación en Ciencias de la Salud (INICSA/CONICET), Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Argentina
7 shared publicationsH. Walter Rivarola
Centro de Investigación de la Enfermedad de Chagas y Leishmaniasis (CIECyL), Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Argentina; Instituto de Investigación en Ciencias de la Salud (INICSA/CONICET), Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Argentina
6 shared publicationsAlicia R. Fernández
Universidad Nacional de Córdoba
5 shared publications
Latest Publications
- 22 February 2026
- Published by Elsevier in Acta Tropica
- Vol. 276, 108030
Parasite burden, genetic profiling and geographic distribution of Trypanosoma cruzi detected in chronic Chagas disease patients from Córdoba, Argentina
- 22 February 2026
- Published by Elsevier in Acta Tropica
- Vol. 276, 108030
Parasite burden, genetic profiling and geographic distribution of Trypanosoma cruzi detected in chronic Chagas disease patients from Córdoba, Argentina
- 1 December 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 151
Evaluation of Apolipoprotein-A1 genetic polymorphisms as biomarkers for Chagas cardiomyopathy in patients from Córdoba, Argentina
- 1 December 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 151
Evaluation of Apolipoprotein-A1 genetic polymorphisms as biomarkers for Chagas cardiomyopathy in patients from Córdoba, Argentina
- 13 September 2025
- Published by Elsevier in Bioorganic Chemistry
- Vol. 165, 108983
Photoinactivation of Leishmania amazonensis by Soranjidiol and white LED: Unraveling photodynamic and cell death mechanisms
- 13 September 2025
- Published by Elsevier in Bioorganic Chemistry
- Vol. 165, 108983
Photoinactivation of Leishmania amazonensis by Soranjidiol and white LED: Unraveling photodynamic and cell death mechanisms
- 1 June 2021
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 148 (13) , 1595-1601
Differential tissue distribution of discrete typing units after drug combination therapy in experimental Trypanosoma cruzi mixed infection
The aim of the present work was to evaluate the distribution of the different clones of the parasite prevailing after treatment with benznidazole (BZ) and clomipramine (CLO), in mice infected with Trypanosoma cruzi, Casibla isolate which consists of a mixture of two discrete typing units (DTUs). Albino Swiss mice were infected and treated with high and low concentrations of BZ (100 or 6.25 mg/kg), CLO (5 or 1.25 mg/kg), or the combination of both low doses (BZ6.25 + CLO1.25), during the acute phase of experimental infection. Treatment efficacy was evaluated by comparing parasitaemia, survival and tissular parasite presence. For DTUs genotyping, blood, skeletal and cardiac muscle samples were analysed by multiplex quantitative polymerase chain reaction. The combined treatment had similar outcomes to BZ6.25; BZ100 was the most effective treatment, but it failed to reach parasite clearance and produced greater histological alterations. Non-treated mice and the ones treated with monotherapies showed both DTUs while BZ6.25 + CLO1.25 treated mice showed only TcVI parasites in all the tissues studied. These findings suggest that the treatment may modify the distribution of infecting DTUs in host tissues. Coinfection with T. cruzi clones belonging to different DTUs reveals a complex scenario for the treatment of Chagas disease and search for new therapies.
- 1 June 2021
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 148 (13) , 1595-1601
Differential tissue distribution of discrete typing units after drug combination therapy in experimental Trypanosoma cruzi mixed infection
The aim of the present work was to evaluate the distribution of the different clones of the parasite prevailing after treatment with benznidazole (BZ) and clomipramine (CLO), in mice infected with Trypanosoma cruzi, Casibla isolate which consists of a mixture of two discrete typing units (DTUs). Albino Swiss mice were infected and treated with high and low concentrations of BZ (100 or 6.25 mg/kg), CLO (5 or 1.25 mg/kg), or the combination of both low doses (BZ6.25 + CLO1.25), during the acute phase of experimental infection. Treatment efficacy was evaluated by comparing parasitaemia, survival and tissular parasite presence. For DTUs genotyping, blood, skeletal and cardiac muscle samples were analysed by multiplex quantitative polymerase chain reaction. The combined treatment had similar outcomes to BZ6.25; BZ100 was the most effective treatment, but it failed to reach parasite clearance and produced greater histological alterations. Non-treated mice and the ones treated with monotherapies showed both DTUs while BZ6.25 + CLO1.25 treated mice showed only TcVI parasites in all the tissues studied. These findings suggest that the treatment may modify the distribution of infecting DTUs in host tissues. Coinfection with T. cruzi clones belonging to different DTUs reveals a complex scenario for the treatment of Chagas disease and search for new therapies.
- Open Access
- 1 December 2020
- Published by Universidad Nacional de Córdoba in Revista de la Facultad de Ciencias Médicas de Córdoba
- Vol. 77 (4) , 276-280
Goniometría del movimiento de flexo-extensión de tobillo: análisis comparativo entre método de referencias óseas y método 0 neutral
Introducción: En la goniometría de tobillo se utilizan dos métodos diferentes, el método cero neutral (M0N) y el método de referencias óseas (MRO). Además, el M0N tiene un subtipo (M0I), con una técnica diferente. Objetivo: Determinar el promedio de la amplitud de flexo-extensión de tobillo, medida en diferentes posiciones corporales, utilizando M0N, M0I y MRO, en adultos jóvenes de ambos sexos, con el objetivo de aportar evidencia para que la goniometría de tobillo sea más fiable. Material y métodos: Se estudiaron 190 alumnos de la Escuela de Kinesiología y Fisioterapia, utilizando los tres métodos de medición articular en 4 posiciones corporales diferentes; se evaluó la amplitud de flexo-extensión en un tobillo por alumno. Resultados: En la mayoría de las posiciones, las mediciones fueron diferentes en los tres métodos comparados (P<0,05). Los métodos M0 y M0I arrojaron resultados similares en algunas comparaciones puntuales. La posición del paciente también influye significativamente en el resultado obtenido. La flexión dorsal de tobillo fue similar entre hombres y mujeres en la mayoría de los métodos y posiciones del paciente, no así la flexión plantar que fue mayor en las mujeres en todos los casos (P<0,0001). El valor completo de flexo-extensión, en la mayoría de los casos fue mayor en las mujeres que en los varones (P<0,001). Conclusiones: Tanto el método como la posición del paciente influyen significativamente en los resultados de la medición goniométrica. El género influye en la amplitud articular de la flexión plantar de tobillo, independientemente del método de medición utilizado.
- 1 December 2020
- Published by Universidad Nacional de Córdoba in Revista de la Facultad de Ciencias Médicas de Córdoba
- Vol. 77 (4) , 276-280
Open AccessGoniometría del movimiento de flexo-extensión de tobillo: análisis comparativo entre método de referencias óseas y método 0 neutral
Introducción: En la goniometría de tobillo se utilizan dos métodos diferentes, el método cero neutral (M0N) y el método de referencias óseas (MRO). Además, el M0N tiene un subtipo (M0I), con una técnica diferente. Objetivo: Determinar el promedio de la amplitud de flexo-extensión de tobillo, medida en diferentes posiciones corporales, utilizando M0N, M0I y MRO, en adultos jóvenes de ambos sexos, con el objetivo de aportar evidencia para que la goniometría de tobillo sea más fiable. Material y métodos: Se estudiaron 190 alumnos de la Escuela de Kinesiología y Fisioterapia, utilizando los tres métodos de medición articular en 4 posiciones corporales diferentes; se evaluó la amplitud de flexo-extensión en un tobillo por alumno. Resultados: En la mayoría de las posiciones, las mediciones fueron diferentes en los tres métodos comparados (P<0,05). Los métodos M0 y M0I arrojaron resultados similares en algunas comparaciones puntuales. La posición del paciente también influye significativamente en el resultado obtenido. La flexión dorsal de tobillo fue similar entre hombres y mujeres en la mayoría de los métodos y posiciones del paciente, no así la flexión plantar que fue mayor en las mujeres en todos los casos (P<0,0001). El valor completo de flexo-extensión, en la mayoría de los casos fue mayor en las mujeres que en los varones (P<0,001). Conclusiones: Tanto el método como la posición del paciente influyen significativamente en los resultados de la medición goniométrica. El género influye en la amplitud articular de la flexión plantar de tobillo, independientemente del método de medición utilizado.
- Open Access
- 19 March 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Genetic polymorphisms of IL17A associated with Chagas disease: results from a meta-analysis in Latin American populations
Genetic factors and the immunologic response have been suggested to determine the susceptibility against the infection and the outcome of Chagas disease. In the present study, we analysed three IL17A genetic variants (rs4711998, rs8193036 and rs2275913) regarding the predisposition to Trypanosoma cruzi infection and the development of chronic Chagas cardiomyopathy (CCC) in different Latin American populations. A total of 2,967 individuals from Colombia, Argentina, Bolivia and Brazil, were included in this study. The individuals were classified as seronegative and seropositive for T. cruzi antigens, and this last group were divided into asymptomatic and CCC. For T. cruzi infection susceptibility, the IL17A rs2275913*A showed a significant association in a fixed-effect meta-analysis after a Bonferroni correction (P = 0.016, OR = 1.21, 95%CI = 1.06–1.41). No evidence of association was detected when comparing CCC vs. asymptomatic patients. However, when CCC were compared with seronegative individuals, it showed a nominal association in the meta-analysis (P = 0.040, OR = 1.20, 95%CI = 1.01–1.45). For the IL17A rs4711998 and rs8193036, no association was observed. In conclusion, our results suggest that IL17A rs2275913 plays an important role in the susceptibility to T. cruzi infection and could also be implicated in the development of chronic cardiomyopathy in the studied Latin American population.
- 19 March 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Open AccessGenetic polymorphisms of IL17A associated with Chagas disease: results from a meta-analysis in Latin American populations
Genetic factors and the immunologic response have been suggested to determine the susceptibility against the infection and the outcome of Chagas disease. In the present study, we analysed three IL17A genetic variants (rs4711998, rs8193036 and rs2275913) regarding the predisposition to Trypanosoma cruzi infection and the development of chronic Chagas cardiomyopathy (CCC) in different Latin American populations. A total of 2,967 individuals from Colombia, Argentina, Bolivia and Brazil, were included in this study. The individuals were classified as seronegative and seropositive for T. cruzi antigens, and this last group were divided into asymptomatic and CCC. For T. cruzi infection susceptibility, the IL17A rs2275913*A showed a significant association in a fixed-effect meta-analysis after a Bonferroni correction (P = 0.016, OR = 1.21, 95%CI = 1.06–1.41). No evidence of association was detected when comparing CCC vs. asymptomatic patients. However, when CCC were compared with seronegative individuals, it showed a nominal association in the meta-analysis (P = 0.040, OR = 1.20, 95%CI = 1.01–1.45). For the IL17A rs4711998 and rs8193036, no association was observed. In conclusion, our results suggest that IL17A rs2275913 plays an important role in the susceptibility to T. cruzi infection and could also be implicated in the development of chronic cardiomyopathy in the studied Latin American population.
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 62, e15
Analysis of mitochondrial enzymatic activity in blood lymphomonocyte fractions during infection with different Trypanosoma cruzi strains
Proinflammatory and inflammatory mediators induced by Trypanosoma cruzi infection increase the oxidative stress, generating toxicity for cells targeting mitochondria of different tissues. We studied the activity of citrate synthase and complexes I-IV of respiratory chain in mitochondria of blood lymphomonocyte fraction, from albino Swiss mice infected with different isolates of T. cruzi , during Chagas disease evolution. Complexes I-IV were modified in infected groups (p<0.05) in all the stages, and an inflammatory process of different magnitudes was detected in the heart and skeletal muscle according to the isolate. The citrate synthase activity presented modifications in the SGO Z12 and the Tulahuen group (p<0.05). Hearts showed fiber fragmentation and fibrosis; skeletal muscle presented inflammatory infiltrates and in the Tulahuen infected group, there were also amastigote nests. The inflammatory processes produced an oxidative stress that induced different alterations of mitochondrial enzymes activities in the lymphomonocyte fraction that can be detected by a simple blood extraction, suggesting that they could be used as disease markers, especially in the indeterminate phase of Chagas disease.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 62, e15
Open AccessAnalysis of mitochondrial enzymatic activity in blood lymphomonocyte fractions during infection with different Trypanosoma cruzi strains
Proinflammatory and inflammatory mediators induced by Trypanosoma cruzi infection increase the oxidative stress, generating toxicity for cells targeting mitochondria of different tissues. We studied the activity of citrate synthase and complexes I-IV of respiratory chain in mitochondria of blood lymphomonocyte fraction, from albino Swiss mice infected with different isolates of T. cruzi , during Chagas disease evolution. Complexes I-IV were modified in infected groups (p<0.05) in all the stages, and an inflammatory process of different magnitudes was detected in the heart and skeletal muscle according to the isolate. The citrate synthase activity presented modifications in the SGO Z12 and the Tulahuen group (p<0.05). Hearts showed fiber fragmentation and fibrosis; skeletal muscle presented inflammatory infiltrates and in the Tulahuen infected group, there were also amastigote nests. The inflammatory processes produced an oxidative stress that induced different alterations of mitochondrial enzymes activities in the lymphomonocyte fraction that can be detected by a simple blood extraction, suggesting that they could be used as disease markers, especially in the indeterminate phase of Chagas disease.
- Open Access
- 21 November 2019
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 13 (11) , e0007859
Association of IL18 genetic polymorphisms with Chagas disease in Latin American populations
Host genetic factors have been suggested to play an important role in the susceptibility to Chagas disease. Given the influence of interleukin 18 (IL-18) in the development of the disease, in the present study, we analyzed three IL18 genetic variants (rs2043055, rs1946518, rs360719) regarding the predisposition to Trypanosoma cruzi infection and the development of chronic Chagas cardiomyopathy (CCC), in different Latin America populations. Genetic data of 3,608 patients from Colombia, Bolivia, Argentina, and Brazil were meta-analyzed to validate previous findings with increased statistical power. Seropositive and seronegative individuals were compared for T. cruzi infection susceptibility. In the Colombian cohort, the allelic frequencies of the three variants showed a significant association, with adjustment for sex and age, and also after applying multiple testing adjustments. Among the Colombian and Argentinean cohorts, rs360719 showed a significant genetic effect in a fixed-effects meta-analysis after a Bonferroni correction (OR: 0.76, CI: 0.66–0.89, P = 0.001). For CCC, the rs2043055 showed an association with protection from cardiomyopathy in the Colombian cohort (OR: 0.79, CI: 0.64–0.99, P = 0.037), with adjustment for sex and age, and after applying multiple testing adjustments. The meta-analysis of the CCC vs. asymptomatic patients from the four cohorts showed no evidence of association. In conclusion, our results validated the association found previously in the Colombian cohort suggesting that IL18 rs360719 plays an important role in the susceptibility to T. cruzi infection and no evidence of association was found between the IL18 genetic variants and CCC in the Latin American population studied. Chagas disease is a parasitic infection caused by the protozoon Trypanosoma cruzi, is the third most common parasitic infection worldwide, the most important in Latin America and is an emerging disease in non-endemic countries. Actually, millions of people live in areas of exposure and are at risk of contracting the infection. Most of the infected individuals remain asymptomatic for all of their lives, but around 30% of the chronically infected individuals develop irreversible cardiac damage and 10% digestive lesions. Host genetic factors have been suggested to play an important role in the susceptibility or resistance to Chagas disease. In this work, we investigated variants of the IL18 gene in different Latin America populations. This gene encoded the interleukin-18, which is involved in the immune response to intracellular pathogens like T. cruzi. Our results showed that an IL18 gene variant plays an important role in the protection against T. cruzi infection.
- 21 November 2019
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 13 (11) , e0007859
Open AccessAssociation of IL18 genetic polymorphisms with Chagas disease in Latin American populations
Host genetic factors have been suggested to play an important role in the susceptibility to Chagas disease. Given the influence of interleukin 18 (IL-18) in the development of the disease, in the present study, we analyzed three IL18 genetic variants (rs2043055, rs1946518, rs360719) regarding the predisposition to Trypanosoma cruzi infection and the development of chronic Chagas cardiomyopathy (CCC), in different Latin America populations. Genetic data of 3,608 patients from Colombia, Bolivia, Argentina, and Brazil were meta-analyzed to validate previous findings with increased statistical power. Seropositive and seronegative individuals were compared for T. cruzi infection susceptibility. In the Colombian cohort, the allelic frequencies of the three variants showed a significant association, with adjustment for sex and age, and also after applying multiple testing adjustments. Among the Colombian and Argentinean cohorts, rs360719 showed a significant genetic effect in a fixed-effects meta-analysis after a Bonferroni correction (OR: 0.76, CI: 0.66–0.89, P = 0.001). For CCC, the rs2043055 showed an association with protection from cardiomyopathy in the Colombian cohort (OR: 0.79, CI: 0.64–0.99, P = 0.037), with adjustment for sex and age, and after applying multiple testing adjustments. The meta-analysis of the CCC vs. asymptomatic patients from the four cohorts showed no evidence of association. In conclusion, our results validated the association found previously in the Colombian cohort suggesting that IL18 rs360719 plays an important role in the susceptibility to T. cruzi infection and no evidence of association was found between the IL18 genetic variants and CCC in the Latin American population studied. Chagas disease is a parasitic infection caused by the protozoon Trypanosoma cruzi, is the third most common parasitic infection worldwide, the most important in Latin America and is an emerging disease in non-endemic countries. Actually, millions of people live in areas of exposure and are at risk of contracting the infection. Most of the infected individuals remain asymptomatic for all of their lives, but around 30% of the chronically infected individuals develop irreversible cardiac damage and 10% digestive lesions. Host genetic factors have been suggested to play an important role in the susceptibility or resistance to Chagas disease. In this work, we investigated variants of the IL18 gene in different Latin America populations. This gene encoded the interleukin-18, which is involved in the immune response to intracellular pathogens like T. cruzi. Our results showed that an IL18 gene variant plays an important role in the protection against T. cruzi infection.
- 1 June 2018
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 222, 29-33
Differential tissue distribution of Trypanosoma cruzi during acute experimental infection: Further evidence using natural isolates
- 1 June 2018
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 222, 29-33
Differential tissue distribution of Trypanosoma cruzi during acute experimental infection: Further evidence using natural isolates
- 1 June 2018
- Published by Elsevier in Experimental Parasitology
- Vol. 189, 19-27
In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach
- 1 June 2018
- Published by Elsevier in Experimental Parasitology
- Vol. 189, 19-27
In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach